Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial publishing date : 2021 - 09 - 09 save search
Rezolute Announces Initiation of Dosing in the Second Cohort of its Phase 2b Trial of RZ358 for Congenital Hyperinsulinism
Published: 2021-09-09 (Crawled : 22:00) - biospace.com/
RZLT 4 | $2.91 1.75% 1.72% 340K
|
Technology Services
|
| O: -0.51%
H: 4.37%
C: 1.52%
phase 2 insulin phase 2b trial
Corcept Announces Presentation of Positive Results From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients With Recurrent Platinum-Resistant Ovarian Cancer at ESMO 2021
Published: 2021-09-09 (Crawled : 22:00) - biospace.com/
CORT | News | $22.48 -2.26% -2.31% 1.1M
|
Health Technology
|
| O: 0.05%
H: 0.19%
C: -0.89%
presentation phase 2 positive results positive results cancer ovarian cancer trial
Apellis Announces Top-Line Results from Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA) and Plans to Submit NDA to FDA in the First Half of 2022
Published: 2021-09-09 (Crawled : 22:00) - biospace.com/
APLS G | $49.84 2.3% 2.25% 1.2M
|
Health Technology
|
| O: -0.88%
H: 2.83%
C: 0.94%
fda results phase 3 topline fda ide
Eagle Pharmaceuticals Wins Vasopressin Patent Trial
Published: 2021-09-09 (Crawled : 19:00) - eagleus.com
EGRX | $4.58 -3.98% -4.15% 95K
|
Health Technology
|
| O: -0.86%
H: 1.33%
C: 0.38%
patent trial
Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher DiseaseClinical trial site initiation for Gaucher disease Type 1 on track by year end
Published: 2021-09-09 (Crawled : 15:00) - biospace.com/
FRLN | $6.48 0.0% 0
|
Health Technology
|
| O: 0.0%
H: 1.61%
C: -0.25%
disease treatment orphan drug drug trial pons designation
GreenPower Motor Company to Present at RBC Capital Markets Global Industrials Conference and H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-09 (Crawled : 15:00) - greenpowerbus.com
GP | $1.75 2.84% 98K
|
Consumer Durables
|
| O: -0.99%
H: 3.06%
C: -0.08%
trials trial conference
Global Industry Analysts Predicts the World Industrial Thermal Insulation Market to Reach $9.5 Billion by 2026
Published: 2021-09-09 (Crawled : 15:00) - prnewswire.com
HUN | $23.99 -0.17% 0.0% 1.4M
|
Process Industries
|
| O: -0.67%
H: 2.02%
C: 1.2%
CBT | News | $93.4 0.02% 0.0% 180K
|
Process Industries
|
| O: -0.23%
H: 1.7%
C: 1.15%
MMM | $92.02 -1.05% 0.0% 3.8M
|
Producer Manufacturing
|
| O: -0.19%
H: 0.52%
C: -0.95%
trial
Icosavax Initiates Phase 1/1b Trial of VLP Vaccine Candidate Against Respiratory Syncytial Virus- Phase 1/1b clinical trial will assess the safety and immunogenicity of IVX-121 in healthy adults, including older adults -
Published: 2021-09-09 (Crawled : 15:00) - biospace.com/
ICVX | $15.31 -0.65% 9.3M
|
|
| O: -0.28%
H: 2.89%
C: -0.2%
phase 1 respiratory vaccine trial phase 2 phase 3 order
Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in The Lancet
Published: 2021-09-09 (Crawled : 14:15) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.83%
H: 0.27%
C: -1.98%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -1.2%
H: 0.95%
C: -0.77%
trial t-cell lancet
Sanofi's $3.68 Billion Buy Not Paying Off Yet as Autoimmune Drug Flunks Phase...
Published: 2021-09-09 (Crawled : 14:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.54%
H: 0.23%
C: -0.59%
drug
CG Oncology Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Oncolytic Immunotherapy CG0070 in Combination with OPDIVO® (nivolumab) in Metastatic Urothelial Cancer
Published: 2021-09-09 (Crawled : 13:15) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.74%
H: 0.49%
C: -1.33%
immunotherapy therapy collaboration cancer trial nivolumab
Veru Announces Oral Presentation of Updated Data from the Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-09 (Crawled : 13:15) - biospace.com/
VERU | $1.325 3.92% 3.77% 1.5M
|
Health Technology
|
| O: -1.31%
H: 5.75%
C: 3.73%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.33%
H: 0.06%
C: -1.44%
presentation prostate cancer phase 1 cancer phase 1b sabizabulin phase 2b
PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
PDSB | $3.26 1.88% 1.84% 450K
|
Health Technology
|
| O: 0.59%
H: 6.23%
C: 1.56%
phase 2 cancer biotech iot trial keytruda enroll
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
WVE | $5.01 -1.38% -1.4% 430K
|
Health Technology
|
| O: 0.34%
H: 4.48%
C: 2.7%
huntington disease phase 1 life science trial phase 1b phase 2b huntington’s disease
Syros Announces First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Newly Diagnosed Unfit AML
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
SYRS | $5.055 -1.65% -1.68% 90K
|
Health Technology
|
| O: -0.76%
H: 4.23%
C: 1.54%
trial aml
AGTC to Participate in Clinical Trials in Rare Diseases Conference Panel and Case Study
Published: 2021-09-09 (Crawled : 12:15) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 1.33%
C: -0.67%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.49%
H: 2.35%
C: -0.29%
disease clinical trials trials trial conference rare
Metacrine Achieves Full Enrollment for MET642 Phase 2a Trial in Patients With Nash
Published: 2021-09-09 (Crawled : 12:15) - globenewswire.com
MTCR | $0.5814 -5.14% 84K
|
Health Technology
|
| O: 1.01%
H: 4.0%
C: 0.0%
phase 2 nash trial met642 phase 2b enroll
MindMed to Attend 8th Annual "Mobile in Clinical Trials" Conference
Published: 2021-09-09 (Crawled : 12:00) - biospace.com/
MNMD | $8.45 -4.74% -4.97% 830K
|
n/a
|
| O: 0.0%
H: 1.71%
C: -3.04%
clinical trials mobile trials trial conference
Insights on the Industrial Barcode Scanner Market 2021-2025: Industry Analysis, Market Trends, Market Growth, Opportunities & Forecast 2025 |17000 + Technavio Reports
Published: 2021-09-09 (Crawled : 11:00) - prnewswire.com
HON | News 4 | $194.72 -0.73% -0.74% 3.4M
|
Producer Manufacturing
|
| O: -0.22%
H: 0.48%
C: -0.44%
growth trial market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.